Tumour necrosis factor blockers and structural remodelling in ankylosing spondylitis: what is reality and what is fiction?

Ann Rheum Dis. 2007 Jun;66(6):709-11. doi: 10.1136/ard.2007.071159.

Abstract

A delineation of the differences in pathology between AS and RA

Publication types

  • Editorial

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / physiopathology
  • Bone Remodeling*
  • Humans
  • Spondylitis, Ankylosing / drug therapy*
  • Spondylitis, Ankylosing / physiopathology*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha